SOD1 and amyotrophic lateral sclerosis: In 2018, Maier et al. developed a recombinant human monoclonal antibody (hMAb), specific to human misfolded SOD1 (Maier et al., 2018) and, to avoid mouse anti-human responses upon chronic use, a chimeric version was used in ALS mice models.